Table 4.
Differential metabolites and lipids between RCC and benign groups.
| Compound ID | Description | Score | VIP | P-value | Fold change (RCC/benign) |
|---|---|---|---|---|---|
| Metabolites | |||||
| HMDB00308 | 3b-Hydroxy-5-cholenoic acid | 46.8 | 4.69 | 4.43E-02 | 2.36 |
| HMDB02596 | Deoxycholic acid 3-glucuronide | 53.4 | 3.17 | 8.17E-03 | 3.33 |
| HMDB00631 | Deoxycholic acid glycine conjugate | 55.1 | 4.92 | 1.35E-02 | 2.42 |
| HMDB02579 | Glycochenodeoxycholic acid 3-glucuronide | 51.1 | 3.51 | 1.06E-02 | 7.48 |
| HMDB00641 | L-Glutamine | 44.8 | 2.38 | 1.31E-02 | 2.08 |
| HMDB62332 | N-Docosahexaenoyl GABA | 42.8 | 4.70 | 1.72E-02 | 2.29 |
| HMDB32596 | Sodium glycocholate | 43.7 | 3.58 | 1.90E-02 | 2.71 |
| HMDB60117 | Tetracosahexaenoic acid | 39.7 | 3.78 | 3.80E-02 | 2.66 |
| Lipids | |||||
| 24702281 | 17-Methyltestosterone | 37.1 | 1.47 | 3.95E-02 | 0.60 |
| LMFA07070032 | 2-Hydroxylauroylcarnitine | 45.1 | 1.61 | 1.70E-02 | 1.61 |
| LMFA07070033 | 2-Hydroxymyristoylcarnitine | 42.8 | 1.83 | 4.13E-02 | 1.70 |
| 135638093 | DG(29:2) | 41.8 | 1.05 | 4.15E-02 | 1.58 |
| 14710962 | DG(38:4) | 41.5 | 1.31 | 4.15E-02 | 1.40 |
| 74380326 | N-arachidonoyl tyrosine | 42.9 | 1.41 | 4.90E-02 | 1.92 |
| 160779918 | PC(40:4) | 45.8 | 1.13 | 4.90E-02 | 1.24 |
| 123061482 | PC(O-20:0/22:4) | 50 | 1.15 | 4.15E-02 | 1.21 |
| 123062511 | PE(O-16:0/13:0) | 37.6 | 1.10 | 4.90E-02 | 1.39 |
| 123067375 | PE(P-18:0/20:4) | 46.8 | 1.10 | 4.15E-02 | 0.81 |
| 123064120 | PG(36:3) | 53 | 1.05 | 4.41E-02 | 0.68 |
| 123064655 | PG(40:9) | 37 | 1.58 | 1.63E-02 | 1.73 |
| 123063586 | PS(36:0) | 50.6 | 1.24 | 4.98E-02 | 1.45 |
| 123063234 | PS(38:0) | 48 | 1.21 | 4.90E-02 | 0.40 |
| 123063371 | PS(38:1) | 41.5 | 1.15 | 4.90E-02 | 1.38 |